Hormonal Contraceptive Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET INTRODUCTION
Hormonal Contraceptive are one of the birth control methods that act on the endocrine system of the female to prevent ovulation and avoid fertilization. These also change the uterus, making it unlikely to develop pregnancy.

MARKET DYNAMICS
The Hormonal Contraceptive market is anticipated to grow in the forecast, owing to the factors such as urbanization, increasing family planning, increasing user awareness, rise in menstruating population, and encouragement of government to use contraceptives.

MARKET SCOPE
The "Global Hormonal Contraceptive Market Analysis to 2031" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Hormonal Contraceptive market with detailed market segmentation by Drugs and geography. The global Hormonal Contraceptive market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Hormonal Contraceptive market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Hormonal Contraceptive market is segmented on the basis of Method, Hormones and End User. Based on Method the market is segmented into Combined Oral Contraceptives, Oral Contraceptives, Implanted Contraceptives, Injected Contraceptives, Intrauterine, Transdermal Patch, and Vaginal Ring. Based on Hormones the market is segmented into Androgens, Estrogens, Progestogens, Gonadotropins, Antiandrogens, Others. Based on End User the market is segmented into Hospitals, Homecare, Gynecology Centers, Clinics, and Ambulatory Surgical Centers. REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Hormonal Contraceptive market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Hormonal Contraceptive market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Hormonal Contraceptive market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Hormonal Contraceptive market in these regions.

Hormonal Contraceptive Market Report Analysis

Hormonal Contraceptive Market

• 
  CAGR (2023 - 2031)

  XX%
• Market Size 2023
  US$ XX Million
• Market Size 2031
  US$ XX Million

Report Coverage

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis

• Industry landscape and competition analysis & recent developments
• Detailed company profiles

• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

• Amgen
• Bayer Healthcare Pharmaceuticals
• Cipla Limited
• Glenmark Pharmaceuticals
• Lupin Pharmaceuticals, Inc
• Novartis AG
• Pfizer, Inc
• Piramal Healthcare Limited
• Sun Pharmaceutical Industries Ltd

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

By Method

• Combined Oral Contraceptives
• Oral Contraceptives
• Implanted Contraceptives
• Injected Contraceptives
• Intrauterine
• Transdermal Patch
• Vaginal Ring

By Hormones

• Androgens
• Estrogens
• Progestogens
• Gonadotropins
• Antiandrogens

By End User

• Hospitals
• Homecare
• Gynecology Centers
• Clinics
• Ambulatory Surgical Centers

MARKET PLAYERS
The reports cover key developments in the Hormonal Contraceptive market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Hormonal Contraceptive market are anticipated to lucrative growth opportunities in the future with the rising demand for Hormonal Contraceptive market in the global market. Below mentioned is the list of few companies engaged in the Hormonal Contraceptive market.

The report also includes the profiles of Hormonal Contraceptive market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

• Amgen
• Bayer Healthcare Pharmaceuticals
• Cipla Limited
• Glenmark Pharmaceuticals
• Lupin Pharmaceuticals, Inc
• Novartis AG
• Pfizer, Inc
• Piramal Healthcare Limited
• Sun Pharmaceutical Industries Ltd
• Teva Pharmaceutical Industries

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Hormonal Contraceptive Market Report Scope